<DOC>
	<DOCNO>NCT01426971</DOCNO>
	<brief_summary>Primary Objective : - To compare treatment group reduction pain score least 30 mm visual pain scale ( VAS ) 60 minute study medication intake , compare baseline score ( obtain study medication intake ) . Secondary Objectives : - To assess proportion patient 50 % pain relief , accord VAS score 45 minute study medication intake compare baseline - Determine follow aspect time study medication intake : - Time first perception pain relief - Time onset meaningful pain relief - Reduction pain 15 , 30 , 45 , 60 , 120 240 minute study medication intake , evaluate difference score VAS period baseline - To assess pain accord five item Headache Relief Rating - HRR ( 0 : strong worsen 1 : slight worsen 2 : change 3 : slight improvement 4 : strong improvement ) 15 , 30 , 45 60 minute study medication intake , accord diary complete patient - To check proportion patient require third tablet study medication within 24 hour start study treatment occur - To check timing frequency rescue medication intake , well proportion patient use medication within 24 hour start treatment - Safety assessment .</brief_summary>
	<brief_title>Ibuprofen Versus Ibuprofen Plus Caffeine Treatment Migraine .</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Inclusion criterion : 18 year old less ore equal 65 migraine define accord criterion headache Classification Committee ( ICHD II ) International Headache Society ( HIS ) Migraine first onset 50 year old Occurrence least one episode every two month 8 episode per month previous 3 month , must exceed 14 day per month Pain relief use Over The Counter ( OTC ) medicine least 75 % episode Headache least moderate intensity ( VAS great 30 mm ) , least 75 % episode Absence caffeine black tea least 2 hour one hour drug administration Exclusion criterion : Use acupuncture , homeopathy and/or phytotherapy Use Tryptanes last 30 hour , steroidal antiinflammatory drug last 48 hour analgesic last 15 hour Use analgesic drug product 10 day per month , consecutive , period exceed three month Other type headache migraine , accord International Classification Headache Disorders ( ICHD II ) Chronic complicate migraine , accord ICHD II Coexisting disease significant medical condition investigator judgment interfere and/or prevent individual proper participation study Treatment methotrexate , glucocorticoid , anticoagulant and/or lithium Hypersensibility study medication ( component formula ) , acetyl salicylic , steroidal antiinflammatory drug and/or analgesic antipyretic Nasal polyp , asthma / allergic manifestation Subjects edema , diarrhea and/or vomiting , eat drinking fluid properly accord investigator judgment experience visual disorder Use antihypertensive medication and/or psychoactive last 6 month History anorexia , bulimia and/or mental disorder History tachycardia , arrhythmia , congestive heart failure , coronary artery disease and/or coagulopathy History thyroid disease and/or parathyroid disease , liver disease and/or gastrointestinal History dyspeptic disorder , include gastritis , peptic ulcer and/or gastrointestinal bleeding Impaired renal function test and/or history renal disease , include kidney failure Pregnant ( plan become pregnant course study ) breast feed Woman childbearing age , childbearing potential protected effective contraceptive method birth control . Status pregnancy check pregnancy test serum urine exposure Investigational product . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Migraine</keyword>
</DOC>